Sunil Badve's Publications

About Sunil Badve's Publications

Program Lead, Cardiometabolic Trials, Renal and Metabolic Program

  • Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study

    Nephrology Dialysis Transplantation Date published:

  • Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

    Nephrology Dialysis Transplantation Date published:

  • Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)

    American Journal of Respiratory and Critical Care Medicine Date published:

  • Risk of Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

    Arthritis & Rheumatology Date published:

  • WCN24-2313 LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS

    Kidney International Reports Date published:

  • Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

    Unknown Date published:

  • Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis

    American Journal of Kidney Diseases Date published:

  • Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data

    The Lancet Regional Health - Western Pacific Date published:

  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial

    Kidney International Reports Date published:

  • The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

    Kidney International Reports Date published:

  • QUALITY OF CHRONIC KIDNEY DISEASE CARE IN AUSTRALIAN PRIMARY CARE: ANALYSIS OF A NATIONAL GENERAL PRACTICE DATASET

    Date published:

  • The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)

    PLOS ONE Date published:

  • Iron Biomarkers and Effects of Canagliflozin in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

    Journal of the American Society of Nephrology Date published:

  • Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials

    Journal of the American Society of Nephrology Date published: